MT2A and hepatocellular carcinoma: Taken together, Oncomine and GEPIA databases jointly suggested that the mRNA expression of MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, and MT2A was significantly downregulated in patients with HCC.